News Archive - School of Medicine

Cetuximab Outperforms Durvalumab in Treatment of Head and Neck Cancers

The standard treatment for head and neck cancer, cisplatin, can’t be given to some patients due to pre-existing conditions. A new study compares the efficacy of two alternatives: cetuximab, a monoclonal antibody, and durvalumab, an immune checkpoint inhibitor.

Optical Biosensor Rapidly Detects Monkeypox Virus

Researchers at UC San Diego and their colleagues have developed an optical biosensor that detects the virus that causes mpox. The technology could make diagnosis much faster and cost-effective as the disease continues to spread worldwide.

Curiosity Ignited: Showcasing How AI is Accelerating Discoveries

The inaugural Curiosity Ignited, a signature Homecoming academic symposium explored topics of AI and its connection to interdisciplinary research at UC San Diego. Students, alumni, and thought leaders gathered on Saturday, November 9, for engaging presentations and discussions on how UC San Diego is

Key Pathway Leading to Neurodegeneration in Early Stages of ALS Identified

Researchers at UC San Diego identify a key pathway leading to neurodegeneration in early stages of ALS, hinting at the potential for short-circuiting the progression of the fatal disease if diagnosed early.

CalIT2 Workshop Looks to the Future of Health and Medicine

Throughout the day-long event, participants exchanged views on current issues in health and medicine, from addiction to hospital cybersecurity.

UC San Diego Names 2024 Revelle Medal Recipients

UC San Diego will honor five individuals as recipients of the 2024 Revelle Medal, a prestigious award recognizing sustained, distinguished and extraordinary service to campus. The 2024 Revelle Medal recipients are: Fan Chung Graham, Stephan Haggard, Douglas Richman, M.D., Robert Schooley, M.D. and Jan B. Talbot.